Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9023857
APP PUB NO 20110287111A1
SERIAL NO

13146339

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to new substituted 6-(2-aminobenzylamino)purines, represented by the general formula I, which can be used in CDK inhibition, in particular, in the treatment of viral infections and diseases involving cell proliferation. The invention further includes pharmaceutical preparations containing substituted 6-(2-aminobenzylamino)purines.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERZITA PALACKEHO V OLOMOUCI779 00 OLOMOUC
BIOAPEX S R OSLECHTITELU 813/21 OLOMOUC 779 00

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dolezal, Karel Hlubocky, CZ 27 344
Havlicek, Libor Prague, CZ 10 118
Krystof, Vladimir Olomouc, CZ 14 359
Strnad, Miroslav Olomouc, CZ 49 729
Vojtesek, Borivoj Modrice, CZ 5 43
Zatloukal, Marek Sumperk, CZ 24 305

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 5, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00